The Impact and Role of Pharmacists in the Management of Specialty Therapies

This activity was originally presented as part of the 2024 Asembia Specialty Day of Education Winter Edition.

Program Description

This program will explore the critical role of pharmacists in the management of specialty therapies. Expert panelists will delve into the various stages of the specialty pharmacy process, from patient onboarding to adherence support. Participants will learn how to effectively navigate insurance complexities, manage disease states, and optimize patient outcomes. Additionally, the discussion will encompass best practices for communication between specialty pharmacists and primary care providers to ensure seamless patient care.

Target Audience: Specialty pharmacists
Type of Activity: Knowledge
Release date: December 19, 2024
Expiration date: December 19, 2025
Learner level: Foundational, Intermediate
Time to complete activity: 0.5 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Discuss the various touchpoints within the specialty pharmacy process for patients receiving specialty medications
• Review the communication process between specialty pharmacists and the primary care team

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-24-359-H04-P. The activity is available for CE credit through December 19, 2025.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Ellen R. Dixon, PharmD, CSP, CHN

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta, and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms